Ballicules.com

Glimepiride

AMARYL

Pronunciation: GLYE-me-pye-ride

Glimepiride ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Glimepiride ballicule
Glimepiride AMARYL mascot mnemonic cartoon
Visual mnemonic: Glimepiride mascot
“Amarilla Gleeful emperor ride”
“amarilla” (= yellow)

What it isSulfonylurea that closes beta-cell KATP channels to release insulin; type 2 diabetes.

Why this oneIt is inexpensive and once daily, with less persistent hypoglycemia than glyburide but more than many newer agents.

What limits itHypoglycemia can be prolonged in renal impairment; weight gain and progressive loss of efficacy also limit use.

Glimepiride molecular structure (skeletal formula)
Molecular structure: Glimepiride

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Type 2 diabetes mellitus (adjunct to diet/exercise)Adults1–2 mg QDtitrate to glycemic response8 mg QD
Type 2 diabetes mellitusElderly or renal impairment1 mg QD8 mg QD

Titration Increase in 1–2 mg increments no more frequently than every 1–2 weeks

Renal Start 1 mg QD and titrate slowly (increased hypoglycemia risk)

Hepatic Undefined (increased susceptibility to hypoglycemia; no specific dose adjustment stated)

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy No clear teratogenic risk in humans; discontinue at least 2 weeks before expected delivery (sulfonylureas cross placenta → neonatal hypoglycemia).

Lactation Undefined

Cost

Glimepiride (AMARYL)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/moCostPlus
1 mgtab30 qd$0.73offered
2 mgtab30 qd$1.13offered
4 mgtab30 qd$1.52offered

Generic entry2005

NO BOXED WARNINGS

Principal riskHypoglycemia, prolonged in renal impairment

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger4 / 4
Weight-gain liability2 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryMultiple / indication-, trimester- or formulation-dependent

Defining liabilitySevere and sometimes prolonged hypoglycemia, particularly with renal impairment or missed meals.

Open Glimepiride in the interactive console ↗

Memory aids: interaction avatars

Glimepiride CYP2C9 substrate avatar mnemonic
CYP2C9 substrate

Open Glimepiride in the interactive console ↗